Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of November 29th - December 5th, 2021.
Alerts this week cover papers from Annals of Oncology, The Green Journal and several papers from The New England Journal of Medicine.
Dr Morgan congratulates Dr Toni Choueiri and the Keynote564 team as the FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma.
He also proudly announces that the OncoAlert network and ecancer are media partners with the Binaytara Foundation on the upcoming 2022 summit on cancer health disparities.
You can watch Dr Morgan's previous roundup here
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer